Navidea highlights research on melanoma, oral cancer

Radiopharmaceutical developer Navidea Biopharmaceuticals is directing attentio...Read more on AuntMinnie.comRelated Reading: Navidea touts clinical study using PET/CT for HIV infection Navidea touts early results of RA study Navidea secures Indian regulatory approval for Lymphoseek NYSE accepts Navidea bid to comply with stock listing rules Navidea reports revenue declines in Q4, all of 2021
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news